Defence And Security Tenders

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicinal Products with the Active Ingredient Olanzapine (N05ah03), Without Solid Oral Dosage Forms as Part of a So-Called...

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Sultiam (N03ax03), only Film-Coated Tablets as Part of a So-Called Open House Model.

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Nadroparin, Atc B01ab06 (Obg) for the Period November 1St, 2024 - October 31St, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Interferon Beta-1A (Exclusively for Subcutaneous Use), Atc L03ab07 for the Period November 1St, 2024 - October 31St, 2026

A60, Road Renewal between the Ruesselsheimer Triangle and the Mainspitzdreieck (Km 3.0 - Km 10.0, Direction Mainz)

Conclusion of Non-Exclusive Discount Contracts in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Dexamethasone (S01ba01), only Implants Within the Framework of a So-Called Open House Model...

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Edoxaban (B01af03) as Part of a So-Called Open House Model.

Open House Drug Discount Agreements Eltrombopag, Atc B02bx05

Open House Drug Discount Agreements Infliximab, Atc L04ab02

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Timolol + Brinzolamide, Atc S01ed67 (Obg) for the Period November 1St, 2024 - October 31St, 2026